The Future of
Medical AI
Delivered Weekly
Curated research insights for clinicians and patients. No hype. Just evidence.
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial
A single intravenous dose of DMT, a short-acting psychedelic, with psychological support, rapidly and sustainably reduces depression symptoms in adults with major depressive disorder, according to a recent trial.
Why Medical Professionals Choose Mednosis
We cut through the noise to deliver research that actually matters
Built for Clinicians
Technical notes include study design, sample sizes, confidence intervals, and key limitations
Patient-Friendly
Every article includes plain language explanations your patients can understand
Zero Hype Guarantee
Practice impact ratings tell you exactly how close research is to clinical reality
Latest Research
Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks
PD-1 blockade reprograms antiviral immunity and reduces the HIV reservoir
Tomorrow’s Smart Pills Will Deliver Drugs and Take Biopsies
Leveraging AI to predict patient deterioration
Gene Therapy’s Giant Leap: From Rare Conditions To Common Cures
Get smarter about medical AI every week
Join clinicians and researchers staying ahead of the curve
Trending This Week
Research getting the most attention
Find What Matters to You
Filter research by how close it is to clinical practice
Browse by Specialty
Find research relevant to your field
Never Miss a
Breakthrough
Get curated AI in medicine research delivered weekly. No spam, unsubscribe anytime.
AI in Medicine 101
Learn how to read medical AI research, spot red flags in hype-y articles, and ask the right questions about new technologies.